Enanta Pharmaceuticals Inc
ENTA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001177648
No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Enanta Pharmaceuticals Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 133 | 4 | 122 | −7 |
| Shares | 26.8M | 3.81M | 27.3M | +4.29M (+18.7%) |
| Value | $338.1M | $48.0M | $397.2M | +$107.1M (+36.9%) |
4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jupiter Topco LLC | 3,654,920 | $53.3M | 0.02% |
| SummitTX Capital, L.P. | 257,702 | $3.76M | 0.10% |
| Mackenzie Financial Corp | 67,367 | $982.2K | 0.00% |
| Gsa Capital Partners LLP | 32,486 | $474.0K | 0.03% |
| Alps Advisors Inc | 29,508 | $430.2K | 0.00% |
| Susquehanna Portfolio Strategies, LLC | 17,243 | $251.4K | 0.00% |
| Balyasny Asset Management LLC | 14,915 | $217.5K | 0.00% |
| Global Retirement Partners, LLC | 164 | $2.39K | 0.00% |
| Fortitude Family Office, LLC | 111 | $1.62K | 0.00% |
| SBI Securities Co., Ltd. | 100 | $1.46K | 0.00% |
| Caitong International Asset Management Co., Ltd | 8 | $117 | 0.00% |
| Clearstead Advisors, LLC | 4 | $59 | 0.00% |
Sold out (19)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Diadema Partners LP | 64,952 | $820.3K |
| EAM Investors, LLC | 40,952 | $517.2K |
| Sio Capital Management, LLC | 40,000 | $505.2K |
| Man Group plc | 39,234 | $495.5K |
| Fox Run Management, L.L.C. | 20,501 | $249.7K |
| Persistent Asset Partners Ltd | 16,525 | $208.7K |
| Squarepoint Ops LLC | 13,567 | $171.4K |
| Creative Planning | 12,245 | $154.7K |
| Tudor Investment Corp Et Al | 10,381 | $131.1K |
| Meeder Asset Management Inc | 2,025 | $25.6K |
| Simplex Trading, LLC | 455 | $5.75K |
| MAI Capital Management | 177 | $2.24K |
| Root Financial Partners, LLC | 118 | $1.49K |
| UMA Financial Services, Inc. | 46 | $581 |
| Keating Financial Advisory Services, Inc. | 7 | $88 |
| Twin Peaks Wealth Advisors, LLC | 6 | $76 |
| Advisory Services Network, LLC | 4 | $51 |
| Wealth Preservation Advisors, LLC | 2 | $25 |
| SJS Investment Consulting Inc. | 1 | $13 |
Not filed for Q2 2026 yet (4)
Institutions that held Enanta Pharmaceuticals Inc at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Janus Henderson Group PLC | 3,784,055 | $47.7M |
| CWM, LLC | 21,941 | $277.1K |
| Red Tortoise LLC | 364 | $4.60K |
| Sunbelt Securities, Inc. | 63 | $796 |